Identification of novel small molecules targeting core clock proteins to regulate circadian rhythm
- 1 March 2022
- journal article
- research article
- Published by Elsevier in Current Opinion in Chemical Engineering
- Vol. 35
Abstract
No abstract availableThis publication has 94 references indexed in Scilit:
- The nuclear receptor REV-ERBα mediates circadian regulation of innate immunity through selective regulation of inflammatory cytokinesProceedings of the National Academy of Sciences, 2011
- Identification of SR3335 (ML-176): A Synthetic RORα Selective Inverse AgonistACS Chemical Biology, 2010
- Identification of SR8278, a Synthetic Antagonist of the Nuclear Heme Receptor REV-ERBACS Chemical Biology, 2010
- Cryptochrome mediates circadian regulation of cAMP signaling and hepatic gluconeogenesisNature Medicine, 2010
- Identification of SR1078, a Synthetic Agonist for the Orphan Nuclear Receptors RORα and RORγACS Chemical Biology, 2010
- Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetesNature, 2010
- Differential Association of Circadian Genes with Mood Disorders: CRY1 and NPAS2 are Associated with Unipolar Major Depression and CLOCK and VIP with Bipolar DisorderNeuropsychopharmacology, 2010
- Loss of cryptochrome reduces cancer risk in p53 mutant miceProceedings of the National Academy of Sciences, 2009
- A Functional Genomics Strategy Reveals Rora as a Component of the Mammalian Circadian ClockNeuron, 2004
- The Orphan Nuclear Receptor REV-ERBα Controls Circadian Transcription within the Positive Limb of the Mammalian Circadian OscillatorCell, 2002